WAM Capital Ltd (WAM.AX) stock: key figures, P/E, revenue and dividend
Financials · Investment Banking & Brokerage · Australia · ISIN AU000000WAM2
WAM Capital Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 323.93 m AUD | -161.99 m AUD |
| Gross profit | 323.93 m AUD | -184.70 m AUD |
| Operating income | 304.03 m AUD | -186.72 m AUD |
| Net income | 219.63 m AUD | -125.90 m AUD |
| Diluted EPS – continuing operations | 0.20 AUD | -0.11 AUD |
Full history since 1999, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About WAM Capital Ltd
WAM Capital Limited is a close-ended equity mutual fund launched and managed by Wilson Asset Management (International) Pty Limited. The fund invests in public equity markets of Australia. It makes its investments in companies primarily engaged in the industrial sector. The fund invests in value and growth stocks of small to medium-cap companies. It seeks to invest in short-term arbitrage and mispricing opportunities. The fund has absolute returns focus. It employs fundamental and quantitative analysis with a focus on bottom-up approach to make its investments. The fund benchmarks the performance of its portfolio against the S&P/ASX All Ordinaries Accumulation Index. It conducts in-house research to create its portfolio. WAM Capital Limited was formed on March 8, 1999 and is domiciled in Australia.
More stocks
- Sichuan Goldstone Orient New Material Equipment Co Ltd (300434.SZ)
- Ningbo Ligong Online Monitoring Technology Co Ltd (002322.SZ)
- Paul Hartmann (PHH2.F)
- Aubay SA (AUB.PA)
- Synergie SE (SDG.PA)
- Zhuhai Enpower Electric Co Ltd (300681.SZ)
- Pason Systems Inc. (PSI.TO)
- Global Top E Commerce Co Ltd (002640.SZ)
- Poly Plastic Masterbatch Suzhou Co (300905.SZ)
- HPGC Renmintongtai Pharmaceutical Corp (600829.SS)
- MTT Shipping and Logistics Berhad (5352.KL)
- Shanghai Kaibao Pharmaceutical (300039.SZ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.